Di Ma

1.3k total citations
56 papers, 950 citations indexed

About

Di Ma is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Di Ma has authored 56 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Di Ma's work include Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Di Ma is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Di Ma collaborates with scholars based in China, United States and Hong Kong. Di Ma's co-authors include Jiandie D. Lin, Satchidananda Panda, Jianzhi Zhang, X. Che, Zhi Wang, Wenfeng Qian, Siming Li, Junling Li, Matthew M. Molusky and Rita M. Cowell and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Di Ma

49 papers receiving 941 citations

Peers

Countries citing papers authored by Di Ma

Since Specialization

Citations

This map shows the geographic impact of Di Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Ma more than expected).

Fields of papers citing papers by Di Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Ma. The network helps show where Di Ma may publish in the future.

Co-authorship network of co-authors of Di Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Di Ma. A scholar is included among the top collaborators of Di Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Ma. Di Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exosome-derived SLC12A2-DT promotes macrophage M2 polarization-mediated hepatocellular carcinoma progression 2025 ·International Immunopharmacology ·Jingyi Zhou, (unknown), (unknown), Di Ma, (unknown), Fan Wang, Yuan Lin, Ling Xu, Chen Wang, Qi Li	1
2	Case report: Movement-related neuroplasticity in a patient after spinal cord injury in response to task-oriented bimanual training 2025 ·Frontiers in Human Neuroscience ·Di Ma, (unknown), Shiao‐Yng Chan, Yu Pan, Jiaqi Zhang	0
3	Fabrication of Polyamidoamine Dendrimer-Grafted Magnetic Beads for Enhanced Protein Immobilization and Signal-to-Noise Ratio in Chemiluminescent Immunoassays 2025 ·Langmuir ·(unknown), (unknown), Di Ma, (unknown), (unknown), Shaojun Hu, Zhifei Wang	1
4	Magnetic microspheres with ATRP-synthesized carboxyl polymer brushes for chemiluminescence immunoassays 2025 ·Colloids and Surfaces A Physicochemical and Engineering Aspects ·Di Ma, (unknown), Xinyu Yang, (unknown), Shaojun Hu, Ling‐Xiang Guo, Zhifei Wang, Hong Yang	0
5	Effects of theta burst stimulation on cognitive function and characteristics of blood oxygen alterations based on near-infrared spectroscopy in chronic schizophrenia 2025 ·BMC Psychiatry ·Chunying Gao, Guangjian Li, Xiangrong Zhang, T LU, (unknown), Chen Zhou, Gang Chen, Di Ma, (unknown), (unknown), (unknown), (unknown), Chao Zhou	0
6	Efficacy and safety of PD-1 inhibitors plus metronomic oral vinorelbine in elderly pre-treated patients with metastatic non-small-cell lung cancer. 2024 ·Journal of Clinical Oncology ·Lin Li, (unknown), Jiayi Gao, (unknown), Xiaonan Wu, Min Tang, Xin Nie, Di Ma, Zhe Zhao, (unknown)	0
7	Preoperative geometric parameters predict the outcome of lamellar keratoscleroplasty in patients with limbal dermoids 2023 ·International Ophthalmology ·(unknown), (unknown), Hongxi Wang, (unknown), Di Ma	1
8	Disease monitoring of epidermal growth factor receptor (EGFR)‐mutated non‐small‐cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor DNA 2022 ·Thoracic Cancer ·Yan Li, Ziyi Xu, (unknown), Yixiang Zhu, Di Ma, Yuxin Mu, Jianming Ying, Junling Li, Puyuan Xing	10
9	Robot-Assisted Bimanual Training Improves Hand Function in Patients With Subacute Stroke: A Randomized Controlled Pilot Study 2022 ·Frontiers in Neurology ·Di Ma, Xin Li, Quan Xu, Fei Yang, Yutong Feng, Wenxu Wang, (unknown), Yu‐Cheng Pei, Yu Pan	11
10	Aerosol Concentrations and Fungal Communities Within Broiler Houses in Different Broiler Growth Stages in Summer 2021 ·Frontiers in Veterinary Science ·Guozhong Chen, Di Ma, Qingrong Huang, Wenli Tang, (unknown), Youzhi Li, Linlin Jiang, Hongwei Zhu, Xin Yu, (unknown), Jianlong Zhang, Xingxiao Zhang	11
11	Efficacy and safety of afatinib in a Chinese population with advanced lung adenocarcinoma with sensitive EGFR mutations 2019 ·Thoracic Cancer ·Shouzheng Wang, Puyuan Xing, Ke Yang, Xuezhi Hao, Di Ma, Yuxin Mu, Junling Li	8
12	Efficacy of Crizotinib for Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Patients with Brain Metastasis: A Multicenter, Retrospective Study in China 2019 ·Targeted Oncology ·Puyuan Xing, Shouzheng Wang, (unknown), Di Ma, Xuezhi Hao, Mengzhao Wang, Yan Wang, Shan Li, Tao Xin, Li Liang, Hongge Liang, Yang Du, Zhaohui Zhang, Junling Li	8
13	Clinical features and outcomes ofALKrearranged non‐small cell lung cancer with primary resistance to crizotinib 2019 ·Thoracic Cancer ·Di Ma, Yan Zhang, Puyuan Xing, Xuezhi Hao, Mengzhao Wang, Yan Wang, Shan Li, Tao Xin, Hongge Liang, Yang Du, Zhaohui Zhang, Li Liang, Junling Li	5
14	<p>Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib</p> 2019 ·Cancer Management and Research ·Hongge Liang, Di Ma, Yan Xu, Jing Zhao, Minjiang Chen, Xiaoyan Liu, (unknown), Junling Li, Mengzhao Wang	2
15	A case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita 2018 ·Medicine ·(unknown), Yubiao Guo, Di Ma, (unknown), Decheng Cai, (unknown), Canmao Xie	15
16	Identification of MET exon14 skipping by targeted DNA- and RNA-based next-generation sequencing in pulmonary sarcomatoid carcinomas 2018 ·Lung Cancer ·Yan Li, Lianju Gao, Di Ma, Tian Qiu, Wenbin Li, Weihua Li, Lei Guo, Puyuan Xing, Bing Liu, (unknown), (unknown), Junling Li, Yang Yu, Jianming Ying	19
17	Is there an optimal time to initiate adjuvant chemotherapy to predict benefit of survival in non-small cell lung cancer? 2017 ·Chinese Journal of Cancer Research ·Yutao Liu, Xiaoyu Zhai, Junling Li, Zhiwen Li, Di Ma, Ziping Wang	6
18	Ubiquitin-Specific Protease 2 Regulates Hepatic Gluconeogenesis and Diurnal Glucose Metabolism Through 11β-Hydroxysteroid Dehydrogenase 1 2012 ·Diabetes ·Matthew M. Molusky, Siming Li, Di Ma, Lei Yu, Jiandie D. Lin	50
19	The Genomic Landscape and Evolutionary Resolution of Antagonistic Pleiotropy in Yeast 2012 ·Cell Reports ·Wenfeng Qian, Di Ma, X. Che, Zhi Wang, Jianzhi Zhang	129
20	Arsenic trioxide induces apoptosis in cisplatin-sensitive and -resistant ovarian cancer cell lines 2005 ·International Journal of Gynecological Cancer ·Beihua Kong, Shengdong Huang, Winston Wang, Di Ma, (unknown), Jun Jiang, (unknown), Yang Zhang, Bobo Wang, Bin Cui, Qi Yang	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact